SCISCIOLA, Lucia
 Distribuzione geografica
Continente #
EU - Europa 4.266
AS - Asia 1.910
NA - Nord America 1.585
SA - Sud America 288
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 25
OC - Oceania 5
Totale 8.261
Nazione #
RU - Federazione Russa 2.714
US - Stati Uniti d'America 1.546
IT - Italia 744
SG - Singapore 580
CN - Cina 409
VN - Vietnam 316
IE - Irlanda 313
HK - Hong Kong 251
BR - Brasile 241
DE - Germania 155
IN - India 120
KR - Corea 93
GB - Regno Unito 71
FR - Francia 46
JP - Giappone 46
DK - Danimarca 37
NL - Olanda 37
TR - Turchia 29
FI - Finlandia 27
UA - Ucraina 22
CZ - Repubblica Ceca 18
AR - Argentina 17
CA - Canada 16
PL - Polonia 16
AT - Austria 14
SE - Svezia 14
BD - Bangladesh 13
MX - Messico 13
GR - Grecia 10
PK - Pakistan 10
ID - Indonesia 8
VE - Venezuela 8
EC - Ecuador 6
UZ - Uzbekistan 6
AU - Australia 5
CO - Colombia 5
IL - Israele 5
KE - Kenya 5
BE - Belgio 4
CH - Svizzera 4
ES - Italia 4
IQ - Iraq 4
MA - Marocco 4
PY - Paraguay 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LT - Lituania 3
LV - Lettonia 3
PE - Perù 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
BO - Bolivia 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 8.079
Città #
Moscow 987
San Jose 352
Dublin 313
Singapore 302
Hong Kong 233
Naples 201
Santa Clara 161
Chandler 129
Hefei 104
Ho Chi Minh City 104
Bengaluru 97
Seoul 92
Ashburn 84
Beijing 81
Dallas 81
Hanoi 76
Munich 64
Caserta 51
Aversa 45
The Dalles 43
Council Bluffs 42
Juelsminde 37
Jacksonville 35
New York 35
Los Angeles 34
Princeton 26
Roxbury 26
Bremen 25
Amsterdam 22
Da Nang 21
Istanbul 20
Cambridge 19
Nuremberg 19
Turku 19
Brno 18
Napoli 17
Rome 17
São Paulo 17
Ercolano 16
Milan 15
Warsaw 13
Salerno 12
Wilmington 12
Phoenix 11
Pomigliano d'Arco 11
Haiphong 10
Nha Trang 10
Boardman 9
Chennai 9
Chicago 9
Medford 9
Orem 9
Tyresö 9
Bari 8
Biên Hòa 8
Hillsboro 8
Seattle 8
Vienna 8
Belo Horizonte 7
Brooklyn 7
Falkenstein 7
Giugliano in Campania 7
Bologna 6
Frankfurt am Main 6
London 6
Manchester 6
Memphis 6
Mexico City 6
Montreal 6
Mountain View 6
Quảng Ngãi 6
Rio de Janeiro 6
Thái Nguyên 6
Boston 5
Brasília 5
Curitiba 5
Filderstadt 5
Fisciano 5
Florence 5
Houston 5
Newark 5
Paris 5
San Francisco 5
Seregno 5
Sydney 5
Tashkent 5
Alghero 4
Ann Arbor 4
Barak 4
Boydton 4
Brussels 4
Buenos Aires 4
Campinas 4
Castellammare di Stabia 4
Charlotte 4
Des Moines 4
Hải Dương 4
Lappeenranta 4
New Delhi 4
Niigata 4
Totale 4.468
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 342
Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors 212
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 204
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 188
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 188
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin 182
Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study 175
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients 169
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 166
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts 165
Combined HAT/EZH2 modulation leads to cancer-selective cell death 163
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 161
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 161
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors 160
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 158
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 157
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? 157
Atherosclerotic plaque fissuration and clinical outcomes in pre-diabetics vs. normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of follow-up: Role of micrornas modulation: The atimir study 152
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 151
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 151
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells 149
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide 148
ATTIVATORI DI SIRTUINE E LORO USI 143
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 141
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 139
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 138
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 136
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 134
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia- exposed human cardiomyocytes through comprehensive multi-level analysis 131
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists 131
New insight in molecular mechanisms regulating SIRT6 expression in diabetes: Hyperglycaemia effects on SIRT6 DNA methylation 130
miR-21 in Human Cardiomyopathies 127
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 126
Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complications 125
Myocardial sodium–glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study 123
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 123
Tirzepatide prevents neurodegeneration through multiple molecular pathways 122
Evidence that tirzepatide protects against diabetes-related cardiac damages 122
Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line 121
Obesity-induced neuronal senescence: Unraveling the pathophysiological links 120
Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells 119
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes 118
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction 113
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: Evidence in human cardiomyocyte cell line 112
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes 110
Current Preclinical Applications of Pharmaco-Epigenetics in Cardiovascular Diseases 109
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 107
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia 103
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 101
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors 100
Circulating biomarkers of inflammaging and Alzheimer’s disease to track age-related trajectories of dementia: Can we develop a clinically relevant composite combination? 99
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 98
Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk 94
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 93
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 90
Multi-omics strategies to decode the molecular landscape of cellular senescence 79
On the wake of metformin: Do anti-diabetic SGLT2 inhibitors exert anti-aging effects? 75
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 74
Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine 71
Cardioprotective mechanism of ω-3 fatty acid icosapent ethyl (IPE) in cardiomyocytes: role in high glucose and shear stress-induced mechano-transduction dysregulation 58
Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes 53
Microplastics and Atherosclerosis: Mechanisms 36
Age-related adiponectin resistance in human skeletal muscle dysfunction: in vivo and in vitro evidence 27
Electron Microscopy and Multi-Omics Reveal Mitochondrial Dysfunction and Structural Remodeling in the Hearts of Elderly Mice 20
Correction to: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) (Cardiovascular Diabetology, (2024), 23, 1, (420), 10.1186/s12933-024-02504-8) 11
Totale 8.261
Categoria #
all - tutte 27.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022247 0 5 16 12 46 8 20 10 16 34 17 63
2022/2023597 40 24 25 23 66 35 31 32 284 11 13 13
2023/2024477 24 30 31 22 77 76 12 15 17 33 42 98
2024/20251.220 53 27 20 57 174 122 200 107 149 105 96 110
2025/20265.231 247 356 282 240 381 2.566 339 301 178 193 93 55
2026/2027138 57 81 0 0 0 0 0 0 0 0 0 0
Totale 8.261